Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Pliva announces nine month results

Pliva announces nine month results

7th November 2008

Pliva has today reported financial results for the nine month period up to September 30th 2008.

Organised in accordance with International Financial Reporting Standards, the company announced total revenue of 3,357 million kuna (404 million pounds), a decrease on the prior year’s 4,929 million kuna total.

Excluding sales from the company’s Spain and Italy operations – sold in the last quarter of 2007 – and intragroup sales to Barr, the organisation’s sales increased approximately eight per cent over the previous year.

The business cites growth in its key markets of Russia, Poland and Germany as the reason for growth.

Based in Zagreb, Croatia, the company operates in more than 30 countries and serves as the European headquarters for Barr Pharmaceuticals.

Pliva also announced its earnings before interest and tax as 6.9 million kuna, with a net loss of 107 million kuna.

The Barr group of companies caters for the development, manufacture and marketing of generic and proprietary biopharmaceuticals, pharmaceuticals and active pharmaceutical ingredients.

Marketing more than 120 generic and 27 proprietary products in the US, the group also sells more than 1,025 products globally, in the key markets of Germany, Russia, Poland and Croatia.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.